ALKS 9072, Low Dose
ALK9072-003EXT2
Phase 3 small_molecule completed
Quick answer
ALKS 9072, Low Dose for Schizophrenia is a Phase 3 program (small_molecule) at Alkermes Pharma Ireland with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alkermes Pharma Ireland
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed